Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,410 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Single cell transcriptomes of normal endometrial derived organoids uncover novel cell type markers and cryptic differentiation of primary tumours.
Cochrane DR, Campbell KR, Greening K, Ho GC, Hopkins J, Bui M, Douglas JM, Sharlandjieva V, Munzur AD, Lai D, DeGrood M, Gibbard EW, Leung S, Boyd N, Cheng AS, Chow C, Lim JL, Farnell DA, Kommoss S, Kommoss F, Roth A, Hoang L, McAlpine JN, Shah SP, Huntsman DG. Cochrane DR, et al. Among authors: leung s. J Pathol. 2020 Oct;252(2):201-214. doi: 10.1002/path.5511. Epub 2020 Aug 22. J Pathol. 2020. PMID: 32686114
Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases.
Turbin DA, Leung S, Cheang MC, Kennecke HA, Montgomery KD, McKinney S, Treaba DO, Boyd N, Goldstein LC, Badve S, Gown AM, van de Rijn M, Nielsen TO, Gilks CB, Huntsman DG. Turbin DA, et al. Among authors: leung s. Breast Cancer Res Treat. 2008 Aug;110(3):417-26. doi: 10.1007/s10549-007-9736-z. Epub 2007 Oct 3. Breast Cancer Res Treat. 2008. PMID: 17912629
Distribution and significance of caveolin 2 expression in normal breast and invasive breast cancer: an immunofluorescence and immunohistochemical analysis.
Savage K, Leung S, Todd SK, Brown LA, Jones RL, Robertson D, James M, Parry S, Rodrigues Pinilla SM, Huntsman D, Reis-Filho JS. Savage K, et al. Among authors: leung s. Breast Cancer Res Treat. 2008 Jul;110(2):245-56. doi: 10.1007/s10549-007-9718-1. Epub 2007 Oct 3. Breast Cancer Res Treat. 2008. PMID: 17912630
Can clinically relevant prognostic subsets of breast cancer patients with four or more involved axillary lymph nodes be identified through immunohistochemical biomarkers? A tissue microarray feasibility study.
Crabb SJ, Bajdik CD, Leung S, Speers CH, Kennecke H, Huntsman DG, Gelmon KA. Crabb SJ, et al. Among authors: leung s. Breast Cancer Res. 2008;10(1):R6. doi: 10.1186/bcr1847. Epub 2008 Jan 14. Breast Cancer Res. 2008. PMID: 18194560 Free PMC article. Clinical Trial.
Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.
Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A, Prentice LM, Miller D, Santos J, Swenerton K, Gilks CB, Huntsman D. Köbel M, et al. Among authors: leung s. PLoS Med. 2008 Dec 2;5(12):e232. doi: 10.1371/journal.pmed.0050232. PLoS Med. 2008. PMID: 19053170 Free PMC article.
2,410 results